Abstract
The development of cancer is a multistage process which is generally divided into initiation, promotion and progression phases. In the initiation phase, a carcinogen, either directly or after metabolic activation to a reactive molecule, interacts with intracellular macromolecules (DNA, proteins). This may cause DNA damage, which, if not repaired, can result in mutations and genetic damage. These mutations eventually lead to an altered expression of oncogenes and tumor suppressor genes or, e.g., continuous activation of protein kinases during the promotion phase, and finally result in modified cell structure, uncontrolled cell proliferation, tumor growth, and metastases in the progression phase. This cascade of events offers a variety of targets for chemopreventive intervention to prevent or inhibit the slow process of cellular changes from early genetic lesions to tumor development.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahn D, Putt D, Kresty L, Stoner GD, Fromm D, Hollenberg PF (1996) The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes. Carcinogenesis 17:821–828
Barcelo S, Gardiner JM, Gescher A, Chipman JK (1996) CYP2E1-mediated mechanism of antigenotoxicity of the broccoli constituent sulforaphane. Carcinogenesis 17:277–282
Barcelo S, Mace K, Pfeifer AM, Chipman JK (1998) Production of DNA strand breaks by N-nitrosodimethylamine and 2-amino-3-methylimidazo[4,5-f]quinoline in THLE cells expressing human CYP isoenzymes and inhibition by sulforaphane. Mutat Res 402:111–120
Barch DH, Rundhaugen LM, Stoner GD, Pillay NS, Rosche WA (1996) Structure-function relationships of the dietary anticarcinogen ellagic acid. Carcinogenesis 17:265–269
Ben Aziz A, Grossman S, Ascarelli I, Budowski P (1970) Linoleate oxidation induced by lipoxygenase and heme proteins: a direct spectrophotometric assay. Anal Biochem 34:88–100
Bhat KP, Lantvit D, Christov K, Mehta RG, Moon RC, Pezzuto JM (2001) Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res 61:7456–7463
Bonnesen C, Eggleston IM, Hayes JD (2001) Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res 61: 6120–6130
Campagne MV, Thibodeaux H, van Bruggen N, Cairns B, Lowe DG (2000) Increased binding activity at an antioxidant-responsive element in the metallothionein-1 promoter and rapid induction of metallothionein-1 and -2 in response to cerebral ischemia and reperfusion. J Neurosci 20:5200–5207
Castonguay A, Gali H, Perchellet EM, Gao XM, Boukharta M, Jalbert G, Okuda T, Yoshida T, Hatano T, Perchellet J-P (1997) Antitumorigenic and antipromoting activities of ellagic acid, ellagitannins and oligomeric anthocyanin and procyani-din. Int J Oncol 10:367–373
Chiba K, Takakuwa T, Tada M, Yoshii T (1992) Inhibitory effect of acylphloroglucinol derivatives on the replication of vesicular stomatitis virus. Biosci Biotechnol Biochem 56:1769–1772
Chung FL, Conaway CC, Rao CV, Reddy BS (2000) Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. Carcinogenesis 21:2287–2291
Conaway CC, Getahun SM, Liebes LL, Pusateri DJ, Topham DK, Botero-Omary M, Chung FL (2000) Disposition of glucosinolates and sulforaphane in humans after ingestion of steamed and fresh broccoli. Nutr Cancer 38:168–178
Constantinou A, Stoner GD, Mehta R, Rao K, Runyan C, Moon R (1995) The dietary anticancer agent ellagic acid is a potent inhibitor of DNA topoisomerases in vitro. Nutr Cancer 23:121–130
Cozzi R, Ricordy R, Bartolini F, Ramadori L, Perticone P, De Salvia R (1995) Taurine and ellagic acid: two differently-acting natural antioxidants. Environ Mol Mutagen 26:248–254
Crespi CL, Miller VP, Penman, BW (1997) Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Anal Biochem 248:188–190
Dekanski JB (1980) Antiprostatic activity of bifluranol, a fluorinated bibenzyl. Br J Pharmacol 71:11–16
Dow LR, Chou TT, Bechle MB, Goddard C, Larson RE (1994) Identification of tricyclic analogs related to ellagic acid as potent/selective tyrosine protein kinase inhibitors. J Med Chem 37:224–231
Festa F, Aglitti T, Duranti G, Ricordy R, Perticone P, Cozzi R (2001) Strong antioxidant activity of ellagic acid in mammalian cells in vitro revealed by the comet assay. Anticancer Res 21(6A):3903–3908
Fimognari C, Nusse M, Cesari R, Iori R, Cantelli-Forti G, Hrelia P (2002) Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the iso-thiocyanate sulforaphane. Carcinogenesis 23:581–586
Gamet-Payrastre L, Li P, Lumeau S, Cassar G, Dupont MA, Chevolleau S, Gasc N, Tulliez J, Terce F (2000) Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res 60:1426–1433
Gamal-Eldeen A, Gerhäuser C, Frank N, Bartsch H (2001) Ellagic acid induces antioxidant mechanisms in cultured human hepatocellular carcinoma cells HUH-7. J Cancer Res Clin Oncol 127:S34
Gerhauser C, Alt A, Heiss E, Gamal-Eldeen A, Klimo K, Knauft J, Neumann I, Scherf H-R, Frank N, Bartsch H, Becker H (2001) Xanthohumol from hop (Humulus lupulus) as a novel potential cancer chemopreventive agent. Proc Am Assoc Cancer Res 42:18
Gerhauser C, Alt A, Heiss E, Gamal-Eldeen A, Klimo K, Knauft J, Neumann I, Scherf H-R, Frank N, Bartsch H, Becker H (2002) Cancer Chemopreventive Activity of Xanthohumol, a Natural Product derived from Hop. Molecular Cancer Therapeutics 1:959–969
Gerhäuser C, Heiss E, Klimo K, Neumann I, Becker H, Eicher Th, Bartsch H (2000) Bibenzyl derivatives as novel lead compounds in chemoprevention. Proc Am Assoc Cancer Res 41:412
Gerhäuser C, Klimo K, Heiss E, Neumann I, Gamal Eldeen A, Knauft J, Liu G, Sitthimonchai S, Frank N (2002) Mechanism-based in vitro Screening of Potential Cancer Chemopreventive Agents. Mutation Research (Fundamental and Molecular Mechanisms of Mutagenesis) (in press)
Gerhauser C, Mar W, Lee SK, Suh N, Luo Y, Kosmeder J, Luyengi L, Fong HH, Kinghorn AD, Moriarty RM, Mehta RG, Constantinou A, Moon RC, Pezzuto JM (1995) Rotenoids mediate potent cancer chemopreventive activity through transcriptional regulation of ornithine decarboxylase. Nat Med 1:260–266
Gerhauser C, You M, Liu J, Moriarty RM, Hawthorne M, Mehta RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes. Cancer Res 57:272–278
Ghisalberti EL (1996) Bioactive acylphloroglucinol derivatives from Eucalyptus species. Phytochem 41:7–22
Haapalainen L, Widen CJ (1970) Thin-layer chromatographic separation of phloroglu-cinol derivatives from Dryopteris ferns at different pH values. Farm Aikak 79: 161–173
Heiss E, Herhaus C, Klimo K, Bartsch H, Gerhauser C (2001) Nuclear factor- kB is a molecular target for sulforaphane-mediated antiinflammatory mechanisms. J Biol Chem 276:32008–32015
Henderson MC, Miranda CL, Stevens JF, Deinzer ML, Buhler DR (2000) In vitro inhibition of human P450 enzymes by prenylated flavonoids from hop Humulus lupulus. Xenobiotica 30:235–251
Holmes-McNary M, Baldwin AS Jr (2000) Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res 60:3477–3483
Hsieh TC, Burfeind P, Laud K, Backer JM, Traganos F, Darzynkiewicz Z, Wu JM (1999) Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. Int J Oncol 15:245–252
Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218–220
Joe AK, Liu H, Suzui M, Vural ME, Xiao D, Weinstein IB (2002) Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 8:893–903
Kapadia GJ, Tokuda H, Konoshima T, Takasaki M, Takayasu J, Nishino H (1996) Antitumor promoting activity of Dryopteris phlorophenone derivatives. Cancer Lett 105:161–165
Kuhl P, Shiloh R, Jha H, Murawski U, Zilliken F (1984) 6,7,4’-Trihydroxyisoflavan: a potent and selective inhibitor of 5-lipoxygenase in human and porcine peripheral blood leukocytes. Prostaglandins 28:783–804
Kuo SM, Leavitt PS (1999) Genistein increases metallothionein expression in human intestinal cells, Caco-2. Biochem Cell Biol 77:79–88
Lee SK, Song L, Mata-Greenwood E, Kelloff GJ, Steele VE, Pezzuto JM (1999) Modulation of in vitro biomarkers of the carcinogenic process by chemopreventive agents. Anticancer Res 19:35–44
Littlefield BA, Gurpide E, Markiewicz L, McKinley B, Hochberg, RB (1990) A simple and sensitive microtiter plate estrogen bioassay based on stimulation of alkaline phosphatase in Ishikawa cells: estrogenic action of delta 5 adrenal steroids. Endocrinology 127:2757–2762
Maheo K, Morel F, Langouet S, Kramer H, Le Ferrec E, Ketterer B, Guillouzo A (1997) Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res 57:3649–3652
Markiewicz L, Hochberg RB, Gurpide E (1992) Intrinsic estrogenicity of some progestagenic drugs. J Steroid Biochem Mol Biol 41:53–58
Mehta RG (2000) Experimental basis for the prevention of breast cancer. Eur J Cancer 36:1275–1282
Miranda CL, Stevens JF, Helmrich A, Henderson MC, Rodriguez RJ, Yang YH, Deinzer ML, Barnes DW, Buhler DR (1999) Antiproliferative and cytotoxic effects of prenylated flavonoids from hop (Humulus lupulus) in human cancer cell lines. Food Chem Toxicol 37:271–285
Miranda CL, Aponso GL, Stevens JF, Deinzer ML, Buhler DR (2000a) Prenylated chal-cones and flavanones as inducers of quinone reductase in mouse Hepa lclc7 cells. Cancer Lett 149:21–29
Miranda CL, Stevens JF, Ivanov V, McCall M, Frei B, Deinzer ML, Buhler DR (2000b) Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. J Agric Food Chem 48:3876–3884
Miyazawa M, Shimamura H, Nakamura S, Sugiura W, Kosaka H, Kameoka H (1999) Moscatilin from Dendrobium nobile, a naturally occurring bibenzyl compound with potential antimutagenic activity. J Agric Food Chem 47:2163–2167
Narayanan BA, Geoffroy O, Willingham MC, Re GG, Nixon DW (1999) p53/p21 (WAF1/CIP1) Expression and its possible role in Gl arrest and apoptosis in ellagic acid treated cancer cells. Cancer Lett 136:215–221
Payen L, Courtois A, Loewert M, Guillouzo A, Fardel O (2001) Reactive oxygen species-related induction of multidrug resistance-associated protein 2 expression in primary hepatocytes exposed to sulforaphane. Biochem Biophys Res Commun 282:257–263
Pengsuparp T, Serit M, Hughes SH, Soejarto DD, Pezzuto JM (1996) Specific inhibition of human immunodeficiency virus type 1 reverse transcriptase mediated by soulattrolide, a coumarin isolated from the latex of Calophyllum teysmannii. J Nat Prod 59:839–842
Perchellet JP, Gali HU, Perchellet EM, Klish DS, Armbrust AD (1992) Antitumor promoting activities of tannin acid, ellagic acid, and several gallic acid derivatives in mouse skin. Basic Life Sci 59:783–801
Pettit GR, Singh SB, Boyd MR, Hamel E, Pettit RK, Schmidt JM, Hogan F (1995) Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(la). J Med Chem 38:1666–1672
Pettit GR, Singh SB, Schmidt JM, Niven ML, Hamel E, Lin CM (1988) Isolation, structure, synthesis, and antimitotic properties of combretastatins B-3 and B-4 from Combretum caffrum. J Nat Prod 51:517–527
Pick E, Mizel D (1981) Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Methods 46:211–226
Prior RL, Cao G (1999) In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Med 27:1173–1181
Prochaska HJ, Santamaria AB (1988) Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screening assay for anti-carcinogenic enzyme inducers. Anal Biochem 169:328–336
Radtke J, Linseisen J, Wolfram G (1998) Phenolic acid intake of adults in a Bavarian subgroup of the national food consumption survey. Zeitschrift für Ernährungswissenschaft 37:190–197
Richon VM, Webb Y, Merger R, Sheppard T, Jursic B, Ngo L, Civoli F, Breslow R, Rifkind RA, Marks PA (1996) Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. Proc Natl Acad Sci USA 93:5705–5708
Ridnour LA, Winters RA, Ercal N, Spitz DR (1999) Measurement of glutathione, glutathione disulfide, and other thiols in mammalian cell and tissue homogenates using high-performance liquid chromatography separation of N-(1-pyrenyl) maleimide derivatives. Methods Enzymol 299:258–267
San RHC, Chan RIM (1987) Inhibitory effect of phenolic compounds on aflatoxin B1 metabolism and induced mutagenesis. Mutat Res 177:229–239
Srinivasan P, Vadhanam MV, Arif JM, Gupta RC (2002) A rapid screening assay for antioxidant potential of natural and synthetic agents in vitro. Int J Oncol 20: 983–986
Steele VE, Kelloff GJ, Wilkinson BP, Arnold JT (1990) Inhibition of transformation in cultured rat tracheal epithelial cells by potential chemopreventive agents. Cancer Res 50:2068–2074
Steele VE, Sharma S, Mehta R, Elmore E, Redpath L, Rudd C, Bagheri D, Sigman CC, Kelloff GJ (1996) Use of in vitro assays to predict the efficacy of chemopreventive agents in whole animals. J Cell Biochem Suppl 26:29–53
Stevens JF, Ivancic M, Hsu VL, Deinzer ML (1997) Prenylflavonoids from Humulus lupulus, Phytochemistry 44:1575–1585
Stoner GD, Morse AM (1997) Isothiocyanates and plant polyphenols as inhibitors of lung and esophageal cancer. Cancer Lett 114:113–119
Stresser DM, Turner SD, McNamara J, Stocker P, Miller VP, Crespi CL, Patten CJ (2000) A high-throughput screen to identify inhibitors of aromatase (CYP19). Anal Biochem 284:427–430
Suh N, Luyengi L, Fong HH, Kinghorn AD, Pezzuto JM (1995) Discovery of natural product chemopreventive agents utilizing HL-60 cell differentiation as a model. Anticancer Res 15:233–239
Takasaki M, Konoshima T, Etoh H, Pal-Singh I, Tokuda H, Nishino H (2000) Cancer chemopreventive activity of euglobal-G1 from leaves of Eucalyptus grandis. Cancer Lett 155:61–65
Takasaki M, Konoshima T, Kozuka M, Tokuda H (1995) Antitumor-promoting activities of euglobals from Eucalyptus plants. Biol Pharm Bull 18:435–438
Takasaki M, Konoshima T, Shingu T, Tokuda H, Nishino H, Iwashima A, Kozuka M (1990) Structures of euglobal-Gl, -G2, and -G3 from Eucalyptus grandis, three new inhibitors of Epstein-Barr virus activation. Chem Pharm Bull (Tokyo) 38: 1444–1446
Tanaka T, Kojima T, Kawamori T, Wang A, Suzui M, Okamoto K, Mori H (1993) Inhibition of 4-nitroquinoline-l-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids. Carcinogenesis 14:1321–1325
Ukeda H, Maeda S, Ishii T, Sawamura M (1997) Spectrophotometric assay for superoxide dismutase based on tetrazolium salt 3′,l-(phenylamino)-carbonyl-3,4-tetrazolium]-bis(4-methoxy-6-nitro)benzenesulfonic acid hydrate reduction by xanthine-xanthine oxidase. Anal Biochem 251:206–209
van Amsterdam FT, Roveri A, Maiorino M, Ratti E, Ursini F (1992) Lacidipine: a dihydropyridine calcium antagonist with antioxidant activity. Free Radic Biol Med 12:183–187
Waffo-Teguo P, Hawthorne ME, Cuendet M, Merillon JM, Kinghorn AD, Pezzuto JM, Mehta RG (2001) Potential cancer-chemopreventive activities of wine stilbenoids and flavans extracted from grape (Vitis vinifera) cell cultures. Nutr Cancer 40: 173–179
Widen CJ, Fraser-Jenkins CR, Reichstein T, Sarvela J (2001) A survey of phenolic compounds in Dryopteris and related fern genera. Part III. Ann Bot Fennici 38:99–138
Wormke M, Castro-Rivera E, Chen I, Safe S (2000) Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells. J Steroid Biochem Mol Biol 72:197–207
Zhang Y, Kensler TW, Cho CG, Posner GH, Talalay P (1994) Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc Natl Acad Sci U S A 91:3147–3150
Zhang Y, Talalay P, Cho CG, Posner GH (1992) A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci U S A 89:2399–2403
Zheng GQ, Ho DK, Elder PJ, Stephens RE, Cottrell CE, Cassady JM (1994) Ohioensins and pallidisetins: novel cytotoxic agents from the moss Polytrichum pallidisetum. J Nat Prod 57:32–41
Zinsmeister HD, Becker H, Eicher Th (1991) Bryophytes, a source of biologically active naturally occurring material? Angew Chem Int Edn Engl 30:130–147
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gerhäuser, C., Frank, N. (2003). New Promising Chemopreventive Agents and Mechanisms. In: Vainio, H.U., Hietanen, E.K. (eds) Mechanisms in Carcinogenesis and Cancer Prevention. Handbook of Experimental Pharmacology, vol 156. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-08602-5_16
Download citation
DOI: https://doi.org/10.1007/978-3-662-08602-5_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-07859-0
Online ISBN: 978-3-662-08602-5
eBook Packages: Springer Book Archive